BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 27318475)

  • 21. Dissecting the conformation of glycans and their interactions with proteins.
    Wang SH; Wu TJ; Lee CW; Yu J
    J Biomed Sci; 2020 Sep; 27(1):93. PubMed ID: 32900381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of the cancer stem cell marker SSEA1 is associated with poor survival in metastatic high-grade serous carcinoma.
    Davidson B; Holth A; Dong HP
    Virchows Arch; 2020 Nov; 477(5):677-685. PubMed ID: 32472195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel Molecular Mechanisms of Gangliosides in the Nervous System Elucidated by Genetic Engineering.
    Furukawa K; Ohmi Y; Yesmin F; Tajima O; Kondo Y; Zhang P; Hashimoto N; Ohkawa Y; Bhuiyan RH; Furukawa K
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32168753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concise Review: Stem/Progenitor Cell Proteoglycans Decorated with 7-D-4, 4-C-3, and 3-B-3(-) Chondroitin Sulfate Motifs Are Morphogenetic Markers of Tissue Development.
    Hayes AJ; Smith SM; Caterson B; Melrose J
    Stem Cells; 2018 Oct; 36(10):1475-1486. PubMed ID: 29893019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A set of cancer stem cell homing peptides associating with the glycan moieties of glycosphingolipids.
    Su YH; Lin TY; Liu HJ; Chuang CK
    Oncotarget; 2018 Apr; 9(29):20490-20507. PubMed ID: 29755667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes of glycoconjugate expression profiles during early development.
    Handa K; Hakomori SI
    Glycoconj J; 2017 Dec; 34(6):693-699. PubMed ID: 27318475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Switching of the core structures of glycosphingolipids from globo- and lacto- to ganglio-series upon human embryonic stem cell differentiation.
    Liang YJ; Kuo HH; Lin CH; Chen YY; Yang BC; Cheng YY; Yu AL; Khoo KH; Yu J
    Proc Natl Acad Sci U S A; 2010 Dec; 107(52):22564-9. PubMed ID: 21149694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glycosphingolipid dynamics in human embryonic stem cell and cancer: their characterization and biomedical implications.
    Ho MY; Yu AL; Yu J
    Glycoconj J; 2017 Dec; 34(6):765-777. PubMed ID: 27549315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Traveling for the glycosphingolipid path.
    Hakomori S
    Glycoconj J; 2000; 17(7-9):627-47. PubMed ID: 11421354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of Fluorescently Labeled SSEA-3, SSEA-4, and Globo-H Glycosphingolipids for Elucidating Molecular Interactions in the Cell Membrane.
    Asano S; Pal R; Tanaka HN; Imamura A; Ishida H; Suzuki KGN; Ando H
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817926
    [TBL] [Abstract][Full Text] [Related]  

  • 31. B3GALT5 knockout alters gycosphingolipid profile and facilitates transition to human naïve pluripotency.
    Lin RJ; Kuo MW; Yang BC; Tsai HH; Chen K; Huang JR; Lee YS; Yu AL; Yu J
    Proc Natl Acad Sci U S A; 2020 Nov; 117(44):27435-27444. PubMed ID: 33087559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carbohydrate to carbohydrate interaction in development process and cancer progression.
    Handa K; Hakomori SI
    Glycoconj J; 2012 Dec; 29(8-9):627-37. PubMed ID: 22610315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unique carbohydrate-carbohydrate interactions are required for high affinity binding between FcgammaRIII and antibodies lacking core fucose.
    Ferrara C; Grau S; Jäger C; Sondermann P; Brünker P; Waldhauer I; Hennig M; Ruf A; Rufer AC; Stihle M; Umaña P; Benz J
    Proc Natl Acad Sci U S A; 2011 Aug; 108(31):12669-74. PubMed ID: 21768335
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of b16 melanoma metastasis by administration of g(m3)- or gg3- liposomes - blocking adhesion of melanoma-cells to endothelial-cells (antiadhesion therapy) via inhibition of g(m3)-gg3cer or g(m3)-laccer interaction.
    Otsuji E; Park Y; Tashiro K; Kojima N; Toyokuni T; Hakomori S
    Int J Oncol; 1995 Feb; 6(2):319-27. PubMed ID: 21556540
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.